Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Guida

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2020
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinibLetizia Porcelli, Annalisa Mazzotta, Marianna Garofoli, et al.
Oncotarget|February 11, 2016
The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy responseRosamaria Pinto, Simona De Summa, Sabino Strippoli, et al.
Scientific Reports|June 28, 2020
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot studyLetizia Porcelli, Marianna Garofoli, Roberta Di Fonte, et al.
Melanoma Research|March 6, 2009
Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patientsLaura Ridolfi, Giammaria Fiorentini, Michele Guida, et al.
Carbohydrate Polymers|August 16, 2025
Harnessing HP-β-CD in zein edible coatings for enhanced sensitive fruits preservationAntonella Vitiello, Ovidio Catanzano, Michele Guida, et al.
ACS Measurement Science Au|April 20, 2026
Anticancer LNA Oligonucleotides Detection through a Simple Paper-Based PlatformAda Raucci, Giovanna Liciberto, Michele Guida, et al.
Frontiers in Oncology|August 1, 2020
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case ReportMichele Guida, Alessandro D'Alò, Anita Mangia, et al.
Biomaterials Advances|February 28, 2026
Core-shell nanofibers integrating growth factor-loaded nanoparticles for spatio-temporal delivery in chronic wound healingOvidio Catanzano, Irene Bonadies, Clara Gamba, et al.
Cancers|March 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal TherapiesValeria Internò, Maria Chiara Sergi, Maria Elvira Metta, et al.
Biochimica Et Biophysica Acta|August 21, 2016
New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutationsAnna Ferretta, Immacolata Maida, Stefania Guida, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 17, 2020
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinibLetizia Porcelli, Annalisa Mazzotta, Marianna Garofoli, et al.
Oncotarget|February 11, 2016
The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy responseRosamaria Pinto, Simona De Summa, Sabino Strippoli, et al.
Scientific Reports|June 28, 2020
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot studyLetizia Porcelli, Marianna Garofoli, Roberta Di Fonte, et al.
Melanoma Research|March 6, 2009
Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patientsLaura Ridolfi, Giammaria Fiorentini, Michele Guida, et al.
Carbohydrate Polymers|August 16, 2025
Harnessing HP-β-CD in zein edible coatings for enhanced sensitive fruits preservationAntonella Vitiello, Ovidio Catanzano, Michele Guida, et al.
ACS Measurement Science Au|April 20, 2026
Anticancer LNA Oligonucleotides Detection through a Simple Paper-Based PlatformAda Raucci, Giovanna Liciberto, Michele Guida, et al.
Frontiers in Oncology|August 1, 2020
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case ReportMichele Guida, Alessandro D'Alò, Anita Mangia, et al.
Biomaterials Advances|February 28, 2026
Core-shell nanofibers integrating growth factor-loaded nanoparticles for spatio-temporal delivery in chronic wound healingOvidio Catanzano, Irene Bonadies, Clara Gamba, et al.
Cancers|March 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal TherapiesValeria Internò, Maria Chiara Sergi, Maria Elvira Metta, et al.
Biochimica Et Biophysica Acta|August 21, 2016
New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutationsAnna Ferretta, Immacolata Maida, Stefania Guida, et al.
Pageof 13